September 2, 2024 by Walter and Eliza Hall Institute of Medical Research Chimeric antigen receptor (CAR) T cells, genetically engineered leukocytes (white blood cells), in their fight against glioblastoma, a deadly type of glioma. Credit: Journal for ImmunoTherapy of Cancer (2024). DOI: 10.1136/jitc-2024-009486Researchers at WEHI have identified a promising new two-in-one treatment that not only...
